Fibromyalgia is one of many conditions that can be classified as “treatment-resistant”. These also include migraines, arthritis, and irritable bowel syndrome.
Each of these conditions includes chronic pain. With fibromyalgia, it is believed that the pain is the result of the condition affecting the way our brain’s pain receptors are handling signals. Scientists have been studying the potential connection between this imbalance in our body’s pain signals and our endocannabinoid system (ECS).
Researchers theorize that the imbalance in our brain’s pain receptors could be associated with the a cannabinoid deficiency that is causing our endocannabinoid system to function improperly. Reviews of studies on the potential of cannabinoids has shown that,
“Cannabinoids have similarly demonstrated the ability to block spinal, peripheral and gastrointestinal mechanisms that promote pain in headache, fibromyalgia, IBS and related disorders.”
By supporting the proper function of our ECS, the potential exists for cannabinoids could provide a new option for individuals dealing with pain management.